SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-138300
Filing Date
2019-05-06
Accepted
2019-05-06 16:19:17
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d369019d10q.htm 10-Q 414195
2 EX-31.1 d369019dex311.htm EX-31.1 6416
3 EX-31.2 d369019dex312.htm EX-31.2 6310
4 EX-32.1 d369019dex321.htm EX-32.1 4194
5 EX-32.2 d369019dex322.htm EX-32.2 4228
  Complete submission text file 0001193125-19-138300.txt   7227653

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ccxi-20190331.xml EX-101.INS 2566212
7 XBRL TAXONOMY EXTENSION SCHEMA ccxi-20190331.xsd EX-101.SCH 40181
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ccxi-20190331_cal.xml EX-101.CAL 40910
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ccxi-20190331_def.xml EX-101.DEF 160443
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ccxi-20190331_lab.xml EX-101.LAB 353413
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ccxi-20190331_pre.xml EX-101.PRE 277075
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Filer) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35420 | Film No.: 19799559
SIC: 2834 Pharmaceutical Preparations